drugset / Trial / NCT04892706

Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel

NCT04892706

Phase 2 Completed 686 enrolled Bausch Health Americas, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The safety and efficacy of once daily application of IDP 126 Gel will be compared to Epiduo® Forte and IDP-126 Vehicle Gel.

Timeline

Start
2021-06-11
Primary completion
2022-09-28
Completion
2022-09-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Adapalene Other / unclassified 0.15 % Topical
Subject Adapalene Other / unclassified 0.3 % Topical
Subject Benzoyl Peroxide Other / unclassified 2.5 % Topical
Subject Benzoyl Peroxide Other / unclassified 3.1 % Topical
Subject Clindamycin Unknown 1.2 % Topical

Indications